Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $515
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained its Buy rating on Intuitive Surgical (NASDAQ:ISRG) and raised the price target from $450 to $515.
July 16, 2024 | 1:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has maintained its Buy rating on Intuitive Surgical and raised the price target from $450 to $515, indicating strong confidence in the company's future performance.
The raised price target from $450 to $515 by Truist Securities suggests a positive outlook for Intuitive Surgical. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100